Regarding the assumption of potential mitochondrial targets, previous studies on the Bcl-2 family protein expression profile suggest a modulation in PCD pathways towards a proapoptotic effect following in vitro treatments of BCC, including MDA-MB-231 cells [8,17]. The gene discussed is BCL2; the disease is skin basal cell carcinoma.